Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

AACR to Host Conference on The Science of Cancer Health Disparities

September 20, 2011 7:39 am | by AACR | News | Comments

Tweet WASHINGTON, D.C. - The American Association for Cancer Research will host its Fourth AACR Conference on The Science of Cancer Health Disparities from Sept. 18-21, 2011, in the Grand Hyatt Washington, located in Washington, D.C. This conference will bring together scientists,...

What Bundled Payments Could Mean for Radiology

September 20, 2011 7:39 am | by Diagnostic Imaging | News | Comments

The way you receive reimbursement for your services could soon transform. There are two problems, however: no one is sure to what degree it will change, and radiologists haven't really had a voice in the conversation.

CMS Testing Four Bundled Payment Models

September 20, 2011 7:39 am | by Diagnostic Imaging | News | Comments

CMS recently extended to Oct. 6 the application deadline for hospitals interested in testing the first of four bundled payment models. It will be a while until you find out while which system the agency ultimately chooses, but this is certain - you will be affected.

Advertisement

Public Workshop ? Magnetic Resonance Imaging Safety, October 25-26, 2011

September 20, 2011 7:30 am | by U.S. Food & Drug Administration | News | Comments

FDA is announcing a public workshop entitled: Magnetic Resonance Resonance Imaging (MRI) Safety Public Workshop. The purpose of the public workshop is to discuss factors affecting the safe use of magnetic resonance imaging MRI and approaches to mitigate

Preetha Reddy, Managing Director, Apollo Hospitals Invited to United Nations Summit on NCDs

September 20, 2011 6:38 am | by Bio-Medicine.Org | News | Comments

NEW YORK, September 20, 2011 /- Preetha Reddy, Managing Director, Apollo Hospitals, was invited to attend the United Nations Summit at New York held by the UN General Assembly for the prevention and control of Non-Communicable Diseases. Non-communicable diseases, such as heart attacks...

Rock Creek Pharmaceuticals Discloses Further Anatabine Patent Filing

September 20, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

GLEN ALLEN, Va., Sept. 20, 2011 /- Rock Creek Pharmaceuticals, a subsidiary of Star Scientific, Inc. (NASDAQ: CIGX ), announced that on September 19, 2011 a utility patent application was filed with the Patent and Trademark Office ("PTO"). This utility patent application is based on...

Valeant Pharmaceuticals to Refinance Senior Secured Credit Facilities

September 20, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, Sept. 20, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced plans to refinance the existing senior secured credit facilities of its wholly owned subsidiary Valeant Pharmaceuticals International.  The existing credit facilities...

AACR Releases Landmark Cancer Progress Report

September 20, 2011 5:35 am | by AACR | News | Comments

Tweet   Report Calls on Congress to Provide Critical Funding Increases for Life-saving Research Supported by the NIH and NCI WASHINGTON, D.C. — The American Association for Cancer Research will unveil the AACR Cancer Progress Report 2011 at 3:30 p.m. ET on Tuesday, Sept. 20,...

Advertisement

Promises Treatment Centers Offers Program Addressing Dramatic Rise in Prescription Pill Addiction by Teens

September 20, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Sept. 20, 2011 /- In response to new government data that shows drug deaths now outnumber traffic fatalities in the United States, Promises Treatment Centers of Los Angeles and Malibu have stepped up efforts to deal to deal with the core of the problem:  prescription...

Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society

September 20, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

EMERYVILLE, Calif., Sept. 20, 2011 /- Bionovo, Inc. (NASDAQ: BNVI ), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that Dr. Mary Tagliaferri, President and Chief Medical Officer of...

MAQUET Cardiovascular Receives FDA 510(k) Clearance and CE Mark for Its New SENSATION PLUSâ„¢ Intra-Aortic Balloon Catheter

September 20, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

MAHWAH, N.J., Sept. 20, 2011 /- MAQUET Cardiovascular, a leading provider of cardiovascular technologies, announced today that it has received both 510(k) clearance from the U.S. Food & Drug Administration (FDA) and CE mark approval from the British Standards Institution (BSi) for its...

Thoratec Presentation at Lazard Capital Markets Circulatory Assist Device Day to be Webcast

September 20, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., Sept. 20, 2011 /- Thoratec Corporation (NASDAQ: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Lazard Capital Markets 3rd Annual Circulatory...

Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R)

September 20, 2011 12:33 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Sept. 19, 2011 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) today announced that Amphastar Pharmaceuticals, Inc., has received U.S. Food and Drug Administration ("FDA") approval of its Abbreviated New Drug Application (ANDA) for Enoxaparin Sodium Injection in the...

Advertisement

Rod Wolford Joins LABSCO Board of Directors

September 19, 2011 1:39 pm | by Bio-Medicine.Org | News | Comments

LOUISVILLE, Ky., Sept. 19, 2011 /- Laboratory Supply Company (LABSCO), the largest privately held supplier of diagnostic instrumentation and clinical laboratory products to hospitals, physician office laboratories, reference labs and other non-acute care settings in the United States, has...

AccuNurse Delivers Real-Time Care Plan Functionality and New Dashboard to Monitor Clinical Trends, Performance and Compliance

September 19, 2011 1:39 pm | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Sept. 19, 2011 /- Vocollect Healthcare Systems ( www.accunurse.com and www.blog.accunurse.com ), a business unit of Intermec, Inc. (NYSE: IN ) announces an expansion of its AccuNurse product to now include full, interdisciplinary clinical care plans, and the release of...

CareFusion Launches New Emergency Transport Ventilator

September 19, 2011 1:38 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 19, 2011 /- CareFusion (NYSE: CFN ), a leading global medical technology company, today announced the launch of the ReVel™ ventilator, a new high performance, portable device designed for pediatric to adult (min. 5Kg) patients who require breathing support...

HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day

September 19, 2011 1:33 pm | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass. and SYDNEY, Sept. 19, 2011 /- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug...

FDA Approved, Non-Invasive Laser Is A Success in Trigeminal Neuralgia Pain Treatment

September 19, 2011 11:40 am | by Bio-Medicine.Org | News | Comments

MYRTLE BEACH, S.C., Sept. 19, 2011 /- Laser Med Center , which specializes in treating Trigeminal Neuralgia, has received an FDA approval for its revolutionary laser device. This is a non-invasive alternative to surgery, which treats pain through nerve tissue regeneration. Trigeminal...

Consistency in Reporting and Communication: Thyroid Ultrasound Imaging

September 19, 2011 11:39 am | by Diagnostic Imaging | News | Comments

If mammography results were reported in the inconsistent way that thyroid ultrasound reports are currently dictated there would be outrage in the medical community. It is important for radiologists to be consistent with their approach and management of these lesions when imaged with...

Appendicitis

September 19, 2011 11:38 am | by Diagnostic Imaging | News | Comments

18-year old female presented in ER with complaint of right sided abdominal pain for two days associated with fever, vomiting, and diarrhea.

South and Central America Cardiovascular Devices Market Outlook to 2017

September 19, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 19, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: South and Central America Cardiovascular Devices Market Outlook to 2017 ...

Innocoll Provides an Update on its Range of Advanced Wound Care and Related Collagen-based Products

September 19, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

ASHBURN, Va., Sept. 19, 2011 /- Innocoll, Inc. announced the following update for its range of advanced wound care and related collagen-based products. Based on a series of recent regulatory approvals and product listings, Innocoll has added six more products in a variety of sponge, film,...

Studying Fluid Overflow in Patients With Devices

September 19, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

BOSTON, Sept. 19, 2011 /- The 15th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a session entitled "Late Breaking Trials," which will highlight recent studies relating to heart failure. Dr. D.J. van Veldhuisen, from The UMC Groningen, The...

Accuray Incorporated to Speak at UBS Global Life Sciences Conference(2)

September 19, 2011 12:38 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Sept. 16, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), the premier radiation oncology company, announced today that its management is scheduled to present at the UBS Global Life Sciences Conference in New York on Tuesday, September 20, 2011 at 4:30 p.m. ET/1:30 p.m....

Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment

September 19, 2011 12:38 am | by Bio-Medicine.Org | News | Comments

THOUSAND OAKS, Calif., Sept. 17, 2011 /- Amgen (NASDAQ: AMGN ) today announced new long-term data showing that Prolia® (denosumab) treatment for up to eight years in postmenopausal women with low bone mass or osteoporosis was associated with a continued increase in bone mineral...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading